Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Holders of 5% or more of TCRT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alaunos Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 13D | 19.99%858.8K shares | New | Oct 15, 20261 filing | Oct 15, 2026 | SEC |
| Postma Robert W | 13D/A | 9.99%514.7K shares | +0.99 ppfrom 9.00% | Jul 1, 20252 filings | Oct 15, 2026 | SEC |
| Price Adrian | 13D/A | 8.60%189.1K shares | 0.00 ppfrom 8.60% | Oct 30, 20255 filings | Mar 5, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
32 Schedule 13D and 13G filings on Alaunos Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 20267:55 PM ET | Postma Robert Wand 1 other | 13D/A | 9.99%514.7K shares | +0.99 ppfrom 9.00% | Oct 13, 2026 | SEC |
| Oct 15, 20264:01 PM ET | Fairmount Funds Management LLCand 4 others | 13D | 19.99%858.8K shares | New | Oct 13, 2026 | SEC |
| Mar 5, 202611:33 AM ET | Price Adrianand 20 others | 13D/A | 8.60%189.1K shares | 0.00 ppfrom 8.60% | Feb 24, 2026 | SEC |
| Feb 24, 20264:56 PM ET | Price Adrianand 20 others | 13D/A | 8.60%189.1K shares | 0.00 ppfrom 8.60% | Feb 24, 2026 | SEC |
| Dec 5, 20253:20 PM ET | Price Adrianand 17 others | 13D/A | 8.60%189.1K shares | 0.00 ppfrom 8.60% | Oct 30, 2025 | SEC |
| Oct 31, 20252:13 PM ET | Price Adrianand 17 others | 13D/A | 8.60%189.1K shares | 0.00 ppfrom 8.60% | Oct 30, 2025 | SEC |
| Oct 30, 20256:48 PM ET | Price Adrianand 17 others | 13D | 8.60%189.1K shares | New | Oct 30, 2025 | SEC |
| Oct 16, 20254:58 PM ET | Strategic EP, LLC | 13G/A | 0.00%0 shares | −6.80 ppfrom 6.80%Below 5% | Oct 14, 2025 | SEC |
| Sep 5, 20255:20 PM ET | PMGC Capital LLCand 1 other | 13D/A | 0.00%0 shares | −5.09 ppfrom 5.09%Below 5% | Aug 22, 2025 | SEC |
| Sep 4, 20256:34 AM ET | Strategic EP, LLC | 13G | 6.80%149.8K shares | New | Aug 21, 2025 | SEC |
| Jul 1, 20257:40 PM ET | Postma Robert Wand 1 other | 13D | 9.00%199.8K shares | New | Jun 24, 2025 | SEC |
| May 14, 20252:59 PM ET | PMGC Capital LLCand 1 other | 13D | 5.09%83.5K shares | New | May 12, 2025 | SEC |
| Feb 13, 20254:15 PM ET | MSD Partners, L.P.and 2 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | MSD Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Discovery Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | MSD Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | MSD Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Discovery Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 20, 2023 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:56 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Discovery Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Hardie Robert D. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | State Street Corp | 13GOld format | – | New | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20227:11 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 12, 2021 | Miller Value Partners, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Hardie Robert D. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Miller Value Partners, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20218:23 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 7, 2021 | Discovery Capital Management, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Alaunos Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Dec 31, 20245:10 PM ET | Vieser JaimeDirector | 3.00K | $6.51K | Dec 31, 2024 | Fidelity Brokerage Services LLC | SEC |
| Sep 1, 202312:20 PM ET | Boyle Kevin S. Sr.Officer | 70.4K | $9.50K | Sep 1, 202310b5-1 | RAYMOND JAMES & ASSOCIATES INC | SEC |